Abstract

BackgroundProgrammed cell death 10 (PDCD10) plays a crucial role in regulating tumor phenotyping, especially in glioblastoma (GBM). Glioma-associated microglia/macrophages (GAMs) in tumor pathological microenvironment contribute to GBM progression. We previously found that the infiltration of GAMs was associated with PDCD10 expression in GBM patients. The present study aims to further explore the regulation of PDCD10 on GAMs in GBM.MethodsOverexpression of PDCD10 in human- and murine-GBM cells was established by lentiviral transduction. Cell behaviors and polarization of primary microglia, microglia- and macrophage-like cells were investigated through indirect co-culture with GBM cells in vitro respectively. The PDCD10-induced release of chemokines was identified by a chemokine protein array. The cross-talk between GBM and microglia as well as macrophages was further studied using selective antagonist SB225002. Finally, an orthotopic homograft mouse model was employed to verify the results of in vitro experiments.ResultsIndirect co-culture with PDCD10-overexpressed GBM cells promoted proliferation and migration of microglia- and macrophage-like cells, and stimulated pro-tumorigenic polarization of primary microglia, microglia- and macrophage-like cells. Pdcd10-upregulated GBM cells triggered a nearly 6-fold increase of CXC motif chemokine ligand 2 (CXCL2) release, which in turn activated CXC chemokine receptor 2 (CXCR2) and downstream Erk1/2 and Akt signaling in primary microglia, microglia- and macrophage-like cells. The blockage of CXCR2 signaling with specific inhibitor (SB225002) abolished microglia- and macrophage-like cell migration induced by PDCD10-upregulated GBM cells. Moreover, Pdcd10-upregulated GL261 cells promoted GAMs recruitment and tumor growth in vivo.ConclusionOur study demonstrates that overexpression of PDCD10 in GBM recruits and activates microglia/macrophages, which in turn promotes tumor progression. CXCL2-CXCR2 signaling mediated by PDCD10 is potentially involved in the crosstalk between GBM cells and GAMs.

Highlights

  • Glioblastoma (GBM) is the most common primary malignant tumor in central nervous system, accounting for 57.3% of gliomas with poor prognosis [1]

  • Characterized as a heterogeneous neoplasm, tumor microenvironment (TME) in GBM consists of various types of cells including tumor cells, endothelial cells, tumor-associated microglia/macrophages (TAMs) and numerous soluble factors like cytokines

  • glioma- associated microglia/ macrophages (GAMs) are composed of resident microglia and monocyte-derived macrophages (MDMs) which enter the brain through the compromised blood brain barrier under pathologic status [5]

Read more

Summary

Introduction

Glioblastoma (GBM) is the most common primary malignant tumor in central nervous system, accounting for 57.3% of gliomas with poor prognosis [1]. TAMs, which are named as glioma- associated microglia/ macrophages (GAMs), account for up to 30% of tumor mass in human GBM [3]. Novel therapeutic strategies targeting TAMs have achieved a curative effect in various cancers in vitro [10, 11]. These medications did not improve the patient prognosis [7]. These facts raised our consideration to define a novel therapeutic approach targeting the interaction of tumors and GAMs. Programmed cell death 10 (PDCD10) plays a crucial role in regulating tumor phenotyping, especially in glioblastoma (GBM). Glioma-associated microglia/ macrophages (GAMs) in tumor pathological microenvironment contribute to GBM progression. The present study aims to further explore the regulation of PDCD10 on GAMs in GBM

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call